Cellid, Co., Ltd. (KOSDAQ:299660)

South Korea · Delayed Price · Currency is KRW

1,956.00

+36.00 (1.88%)

Aug 12, 2026, 12:10 PM KST

Cellid, Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	4,165	4,165	-	480	909.09	-
Revenue Growth	-	-	-	-47.20%	-	-
Gross Profit	697.69	697.69	-4.86	151	905.25	-4.19
Operating Income	-11,980	-11,980	-12,198	-14,911	-13,011	-5,287
Net Income	-12,259	-12,259	-11,611	-22,865	-13,071	-4,126
Earnings Per Share	-743.00	-743.00	-1078.00	-2349.62	-1346.00	-428.00
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '15 Dec 31, 2015
E-commerce	3,807	-	-	-
New Drug Development	358.05	-	-	-
Immunotherapeutic Vaccines	-	480	909.09	639.82

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	9,069	9,069	15,413	18,685	20,113	12,110
Total Debt	13,172	13,172	11,995	11,928	15,821	93.9
Net Cash (Debt)	-4,103	-4,103	3,418	6,757	4,292	12,017
Net Cash Growth	-	-	-49.41%	57.45%	-64.28%	-54.47%
Net Cash Per Share	-248.66	-248.66	317.36	694.38	441.96	1246.51

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-10,315	-10,315	-7,115	-12,216	-8,206	-3,763
Capital Expenditures	-5,908	-5,908	-6,922	-1,203	-3,112	-11,715
Free Cash Flow	-16,224	-16,224	-14,037	-13,419	-11,318	-15,478
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	16.75%	16.75%	-	31.46%	99.58%	-
Operating Margin	-287.64%	-287.64%	-	-3106.53%	-1431.20%	-
Pretax Margin	-294.33%	-294.33%	-	-4763.45%	-1437.76%	-
Profit Margin	-294.33%	-294.33%	-	-4763.45%	-1437.76%	-
FCF Margin	-389.51%	-389.51%	-	-2795.62%	-1244.98%	-

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	-	25.64	-	238.21	525.58	-